Improving Access to T-Cell Therapies in Multiple Myeloma von Derman, Benjamin A

Volltext

MRD-guided treatment cessation in multiple myeloma von Derman, Benjamin A

Volltext

Fair Allocation of Scarce CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma von Derman, Benjamin A, Parker, William F

Volltext

Knowing the unknowns in high risk multiple myeloma von Derman, Benjamin A., Kosuri, Satyajit, Jakubowiak, Andrzej

Volltext

Infection rates are high across the multiple myeloma continuum, not just with bispecific antibodies von Rubinstein, Samuel M., Derman, Benjamin A.

Volltext

Evaluation of administration-related reactions with subcutaneous daratumumab with and without premedication von Padmaraju, Kashyap, Kelly, Kaitlin, Jakubowiak, Andrzej J, Derman, Benjamin A

Volltext

Recommendations for Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy von Derman, Benjamin A, Davis, Andrew M

Volltext

Maybe you can’t drive this CAR? von Derman, Benjamin A.

Volltext

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma von Jasielec, Jagoda K., Kubicki, Tadeusz, Raje, Noopur, Vij, Ravi, Reece, Donna, Berdeja, Jesus, Derman, Benjamin A., Rosenbaum, Cara A., Richardson, Paul, Gurbuxani, Sandeep, Major, Sarah, Wolfe, Brittany, Stefka, Andrew T., Stephens, Leonor, Tinari, Kathryn M., Hycner, Tyler, Rojek, Alexandra E., Dytfeld, Dominik, Griffith, Kent A., Zimmerman, Todd M., Jakubowiak, Andrzej J.

Volltext

Carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone as maintenance therapy after autologous stem-cell transplantation in patients with multiple myeloma (ATLAS): inte... von Dytfeld, Dominik, Wróbel, Tomasz, Jamroziak, Krzysztof, Kubicki, Tadeusz, Robak, Paweł, Walter-Croneck, Adam, Czyż, Jarosław, Tyczyńska, Agata, Druzd-Sitek, Agnieszka, Giannopoulos, Krzysztof, Nowicki, Adam, Szczepaniak, Tomasz, Łojko-Dankowska, Anna, Matuszak, Magdalena, Gil, Lidia, Puła, Bartosz, Rybka, Justyna, Majcherek, Maciej, Usnarska-Zubkiewicz, Lidia, Szukalski, Łukasz, Końska, Agnieszka, Zaucha, Jan Maciej, Walewski, Jan, Mikulski, Damian, Czabak, Olga, Robak, Tadeusz, Lahoud, Oscar B, Zonder, Jeffrey A, Griffith, Kent, Stefka, Andrew, Major, Ajay, Derman, Benjamin A, Jakubowiak, Andrzej J

Volltext

Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous ste... von Derman, Benjamin A., Stefka, Andrew T., Jiang, Ken, McIver, Amanda, Kubicki, Tadeusz, Jasielec, Jagoda K., Jakubowiak, Andrzej J.

Volltext

Sex differences in outcomes in multiple myeloma von Derman, Benjamin A., Langerman, Spencer S., Maric, Maya, Jakubowiak, Andrzej, Zhang, Wei, Chiu, Brian C.‐H.

Volltext

A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma von Derman, Benjamin A, Chari, Ajai, Zonder, Jeffrey, Major, Ajay, Stefka, Andrew T, Jiang, Ken, Karrison, Theodore, Jasielec, Jagoda, Jakubowiak, Andrzej

Volltext

Clinician attitudes and practices toward measurable residual disease in multiple myeloma von Derman, Benjamin A., Jasielec, Jagoda K., Jakubowiak, Andrzej J.

Volltext

Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach? von Derman, Benjamin A., Larson, Richard A.

Volltext

Clinician survey regarding measurable residual disease-guided decision-making in multiple myeloma von Derman, Benjamin A., Jakubowiak, Andrzej J., Thompson, Michael A.

Volltext

Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis von Derman, Benjamin A., Jasielec, Jagoda, Langerman, Spencer S., Zhang, Wei, Jakubowiak, Andrzej J., Chiu, Brian C.-H.

Volltext

Discontinuation of maintenance therapy in multiple myeloma guided by multimodal measurable residual disease negativity (MRD2STOP) von Derman, Benjamin A., Major, Ajay, Cooperrider, Jennifer, Jiang, Ken, Ramsland, Aubrianna, Karrison, Theodore, Kubicki, Tadeusz, Jakubowiak, Andrzej J.

Volltext

Reality check: Real-world evidence to support therapeutic development in hematologic malignancies von Derman, Benjamin A., Belli, Andrew J., Battiwalla, Minoo, Hamadani, Mehdi, Kansagra, Ankit, Lazarus, Hillard M., Wang, Ching-Kun

Volltext

Final analysis of a phase II trial of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma without transplant von Derman, Benjamin A., Cooperrider, Jennifer, Rosenblatt, Jacalyn, Avigan, David E., Rampurwala, Murtuza, Barnidge, David, Major, Ajay, Karrison, Theodore, Jiang, Ken, Ramsland, Aubrianna, Kubicki, Tadeusz, Jakubowiak, Andrzej J.

Volltext